Barriers to cardiovascular risk prevention and management in Germany – an analysis of the EURIKA study

References

• GrahamIAtarDBorch-JohnsenKEuropean Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS)European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)Eur J Cardiovasc Prev Rehabil.200714Suppl 2S111317726407
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakAThe Task Force for the Management of Arterial Hypertension of the European Society of Hypertension, The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J200728121462153617562668
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
   PubMed Web of Science ®Google Scholar
• BhattDLStegPGOhmanEMREACH Registry InvestigatorsInternational prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisJAMA2006295218018916403930
   PubMed Web of Science ®Google Scholar
• KotsevaKWoodDDe BackerGDe BacquerDPyoralaKKeilUEUROASPIRE Study GroupEUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countriesEur J Cardiovasc Prev Rehabil200916212113719287307
   PubMedGoogle Scholar
• De BackerGAmbrosioniEBorch-JohnsenKThird Joint Task Force of the European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEuropean guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEur Heart J200324171601161012964575
   PubMed Web of Science ®Google Scholar
• ConroyRMPyoralaKFitzgeraldAPSCORE Project GroupEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEur Heart J20032411987100312788299
   PubMed Web of Science ®Google Scholar
• HobbsFDErhardtLAcceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) surveyFam Pract200219659660412429661
   PubMed Web of Science ®Google Scholar
• GrahamIMStewartMHertogMGCardiovascular Round Table Task ForceFactors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of CardiologyEur J Cardiovasc Prev Rehabil200613583984517001227
   PubMedGoogle Scholar
• ErhardtLRHobbsFDA global survey of physicians’ perceptions on cholesterol management: the From The Heart studyInt J Clin Pract20076171078108517577295
   PubMed Web of Science ®Google Scholar
• BramlagePThoenesMKirchWLenfantCClinical practice and recent recommendations in hypertension management – reporting a gap in a global survey of 1259 primary care physicians in 17 countriesCurr Med Res Opin200723478379117407635
   PubMed Web of Science ®Google Scholar
• CelentanoAPanicoSPalmieriVCitizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study)Nutr Metab Cardiovasc Dis200313421121714650353
   PubMed Web of Science ®Google Scholar
• Rodriguez-ArtalejoFGuallarEBorghiCEURIKA InvestigatorsRationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA)BMC Public Health20101038220591142
   PubMed Web of Science ®Google Scholar
• BanegasJRLopez-GarciaEDallongevilleJAchievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA studyEur Heart J201132172143215221471134
   PubMed Web of Science ®Google Scholar
• DallongevilleJBanegasJRTubachFSurvey of physicians’ practices in the control of cardiovascular risk factors: the EURIKA studyEur J Cardiovasc Prev Rehabil2011Epub Apr18
   Google Scholar
• GuallarEBanegasJRBlasco-ColmenaresEExcess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe – The EURIKA StudyBMC Public Health20111170421923932
   PubMed Web of Science ®Google Scholar
• BanegasJRLopez-GarciaEDallongevilleJAchievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA studyInt J Cardiol2011Epub Nov4
   Google Scholar
• OneKey databaseBensheim: Cegedim Deutschland GmbHnd Available from http://crm.cegedim.com/country/germany/En/DataOptimization/OneKey/Pages/default.aspxAccessed March 8, 2012
   Google Scholar
• StarkRGSchunkMVMeisingerCRathmannWLeidlRHolleRHORA Study GroupMedical care of type 2 diabetes in German disease management programs: a population-based evaluationDiabetes Metab Res Rev201127438339121308948
   PubMed Web of Science ®Google Scholar
• BestehornKJannowitzCKarmannBPittrowDKirchWCharacteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registryBMC Public Health2009928019653899
   PubMed Web of Science ®Google Scholar
• PruggerCHeuschmannPUKeilUEpidemiology of hypertension in Germany and worldwideHerz2006314287293 German16810468
   PubMed Web of Science ®Google Scholar
• WittchenHUKrausePHoflerMAim, design and methods of the “Hypertension and diabetes screening and awareness” – (HYDRA) studyFortschritte der Medizin2003121Suppl 1211 German14732944
   PubMedGoogle Scholar
• JohanssonHStenlundHLundstromLWeinehallLReorientation to more health promotion in health services – a study of barriers and possibilities from the perspective of health professionalsJ Multidiscip Healthc2010321322421289862
   PubMedGoogle Scholar
• WensingMVan den HomberghPVan DoremalenJGrolRSzecsenyiJGeneral practitioners’ workload associated to practice size rather than chronic care organisationHealth Policy200989112412918599149
   PubMed Web of Science ®Google Scholar
• CullenWGroganLO’ConnorEBuryG“Why are we working so hard?” A cross-sectional survey of factors influencing GP workload in the Eastern Regional Health Authority areaIr Med J200295720921221412227528
   PubMedGoogle Scholar
• WhalleyDBojkeCGravelleHSibbaldBGP job satisfaction in view of contract reform: a national surveyBr J Gen Pract200656523879216464320
   PubMed Web of Science ®Google Scholar
• WensingMvan den HomberghPAkkermansRvan DoremalenJGrolRPhysician workload in primary care: what is the optimal size of practices? A cross-sectional studyHealth Policy200677326026716129508
   PubMed Web of Science ®Google Scholar
• FernandezAGrumbachKVranizanKOsmondDHBindmanABPrimary care physicians’ experience with disease management programsJ Gen Intern Med200116316316711318911
   PubMed Web of Science ®Google Scholar
• MikschALauxGOseDIs there a survival benefit within a German primary care-based disease management program?Am J Manag Care2010161495420148605
   PubMed Web of Science ®Google Scholar
• HagemeisterJSchneiderCABarabasSHypertension guidelines and their limitations – the impact of physicians’ compliance as evaluated by guideline awarenessJ Hypertens200119112079208611677375
   PubMed Web of Science ®Google Scholar
• BabergHTYazarABrechmannTHealth care quality: medication and prevention in patients with and without coronary heart diseaseMed Klin (Munich)200499116 German14716479
   PubMedGoogle Scholar
• ColemanRLStevensRJRetnakaranRHolmanRRFramingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetesDiabetes Care20073051292129317290036
   PubMed Web of Science ®Google Scholar
• McEwanPWilliamsJEGriffithsJDEvaluating the performance of the Framingham risk equations in a population with diabetesDiabet Med200421431832315049932
   PubMed Web of Science ®Google Scholar
• GuzderRNGatlingWMulleeMAMehtaRLByrneCDPrognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom studyDiabet Med200522555456215842509
   PubMed Web of Science ®Google Scholar
• YangXSoWYKongAPDevelopment and validation of a total coronary heart disease risk score in type 2 diabetes mellitusAm J Cardiol2008101559660118308005
   PubMed Web of Science ®Google Scholar
• UlmerHKolleritsBKelleherCDiemGConcinHPredictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44,649 Austrian men and womenEur J Cardiovasc Prev Rehabil200512543344116210929
   PubMedGoogle Scholar
• Bastuji-GarinSDeverlyAMoyseDIntervention as a Goal in Hypertension Treatment Study GroupThe Framingham prediction rule is not valid in a European population of treated hypertensive patientsJ Hypertens200220101973198012359975
   PubMed Web of Science ®Google Scholar
• BrindlePEmbersonJLampeFPredictive accuracy of the Framingham coronary risk score in British men: prospective cohort studyBMJ20033277426126714644971
   PubMed Web of Science ®Google Scholar
• SharmaAMWittchenHUKirchWHYDRA Study GroupHigh prevalence and poor control of hypertension in primary care: cross-sectional studyJ Hypertens200422347948615076152
   PubMed Web of Science ®Google Scholar
• BohlerSGlaesmerHPittrowDDiabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues – rationale for a nationwide primary care project in GermanyExp Clin Endocrinol Diabetes2004112415717015127318
   PubMed Web of Science ®Google Scholar
• HaunerHBramlagePLoschCPrevalence of obesity in primary care using different anthropometric measures – results of the German Metabolic and Cardiovascular Risk Project (GEMCAS)BMC Public Health2008828218694486
   PubMed Web of Science ®Google Scholar
• StewartDCunninghamITHansfordDJohnDMcCaigDMcLayJGeneral practitioners’ views and experiences of over-the-counter simvastatin in ScotlandBr J Clin Pharmacol201070335635920716235
   PubMed Web of Science ®Google Scholar
• FilionKBDelaneyJABrophyJMErnstPSuissaSThe impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research DatabasePharmacoepidemiol Drug Saf20071611416953516
   PubMed Web of Science ®Google Scholar
• BramlagePHasfordJBlood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a reviewCardiovasc Diabetol200981819327149
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRNational Heart, Lung, and Blood Insitute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating CommitteeThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 ReportJAMA2003289192560257212748199
   PubMed Web of Science ®Google Scholar